please keep our community civil. comments should remain on topic and be respectful.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.he would caress her arm and repeatedly tell her, "babe, babe, it's ok."
.
.
.
.